TAKE OFF 14

Basic Policies

Higher profitabilities and strategic investments for future growth

  1. Strengthen and expand existing businesses (growth and priority businesses)
  2. Foster growth businesses (new and international businesses)
  3. Improve profitability

Overview

Initial Targets and Results
TAKE OFF 14
Initial Targets
TAKE OFF 14
Results
(billions of yen)
Meiji HD
(Consolidated)
Net sales 1,190.0 1,161.1
Op. income 40.0 51.5
Op. income ratio 3.4% 4.4%
ROE 7% 8.9%
Food Net sales 1,050.0 1,021.8
Op. Income 30.0 41.6
Pharmaceuticals Net sales 140.0 141.3
Op. Income 10.0 10.0
Total overseas sales 81.0 83.3
(Cumulative 3-year total)
Capital expenditures 161.7 149.0
R&D expenses 73.5 78.3

Results Achieved

Food

  • Priority businesses of probiotics and chocolate led growth
  • Established business foundation for future growth of the enteral formula business
  • Expanded and pursued higher profitability in international business as planed
  • Achieved income growth that covered raw materials costs hike, larger than anticipated, as a results of reducing costs and improving product mix

Pharmaceuticals

  • Achieved strong growth in sales of central nervous system agents and generic drugs
  • Advanced R&D effectively and realized an income from an out-license product
  • Acquired Medoreich Limited for the further growth